Literature DB >> 29500723

Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Carmen A Pfortmueller1,2, Barbara Kabon3, Joerg C Schefold4, Edith Fleischmann3.   

Abstract

Intravenous infusion of crystalloid solutions is one of the most frequently administered medications worldwide. Available crystalloid infusion solutions have a variety of compositions and have a major impact on body systems; however, administration of crystalloid fluids currently follows a "one fluid for all" approach than a patient-centered fluid prescription. Normal saline is associated with hyperchloremic metabolic acidosis, increased rates of acute kidney injury, increased hemodynamic instability and potentially mortality. Regarding balanced infusates, evidence remains less clear since most studies compared normal saline to buffered infusion solutes.; however, buffered solutes are not homogeneous. The term "buffered solutes" only refers to the concept of acid-buffering in infusion fluids but this does not necessarily imply that the solutes have similar physiological impacts. The currently available data indicate that balanced infusates might have some advantages; however, evidence still is inconclusive. Taking the available evidence together, there is no single fluid that is superior for all patients and settings, because all currently available infusates have distinct differences, advantages and disadvantages; therefore, it seems inevitable to abandon the "one fluid for all" strategy towards a more differentiated and patient-centered approach to fluid therapy in the critically ill.

Entities:  

Keywords:  Acetate; Balanced crystalloids; Chloride load; Normal saline

Mesh:

Substances:

Year:  2018        PMID: 29500723     DOI: 10.1007/s00508-018-1327-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  130 in total

1.  Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers.

Authors:  Dileep N Lobo; Zeno Stanga; Mark M Aloysius; Catherine Wicks; Quentin M Nunes; Katharine L Ingram; Lorenz Risch; Simon P Allison
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

2.  Superiority of blood over saline resuscitation from hemorrhagic shock: a 31P magnetic resonance spectroscopy study.

Authors:  D V Mann; M K Robinson; J D Rounds; E DeRosa; D A Niles; J S Ingwall; D W Wilmore; D O Jacobs
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

Review 3.  Anaesthetic perioperative management of patients with pancreatic cancer.

Authors:  Lesley De Pietri; Roberto Montalti; Bruno Begliomini
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

4.  Response of severely malnourished patients to preoperative parenteral nutrition: a randomized clinical trial of water and sodium restriction.

Authors:  M J Gil; G Franch; X Guirao; A Oliva; R Herms; E Salas; M Girvent; A Sitges-Serra
Journal:  Nutrition       Date:  1997-01       Impact factor: 4.008

5.  Association of plasma chloride values with acute kidney injury in the critically ill - a prospective observational study.

Authors:  M Marttinen; E Wilkman; L Petäjä; R Suojaranta-Ylinen; V Pettilä; S T Vaara
Journal:  Acta Anaesthesiol Scand       Date:  2016-02-11       Impact factor: 2.105

6.  Human neutrophil activation and increased adhesion by various resuscitation fluids.

Authors:  P Rhee; D Wang; P Ruff; B Austin; S DeBraux; K Wolcott; D Burris; G Ling; L Sun
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

7.  Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression.

Authors:  Y Le Tulzo; R Shenkar; D Kaneko; P Moine; G Fantuzzi; C A Dinarello; E Abraham
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

8.  Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis.

Authors:  John A Kellum; Mingchen Song; Ramesh Venkataraman
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

9.  Comparison of acetate-1-14C metabolism in uremic and nonuremic dogs.

Authors:  W D Davidson; S J Rorke; L S Guo; R J Morin
Journal:  Am J Clin Nutr       Date:  1978-10       Impact factor: 7.045

10.  Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients.

Authors:  Bandarn Suetrong; Chawika Pisitsak; John H Boyd; James A Russell; Keith R Walley
Journal:  Crit Care       Date:  2016-10-06       Impact factor: 9.097

View more
  4 in total

1.  [Improved quality of stored packed red blood cells by mechanical rinsing].

Authors:  F Münch; A Purbojo; F Wenzel; M Kohl; S Dittrich; M Rauh; R Zimmermann; N Kwapil
Journal:  Anaesthesiologie       Date:  2022-08-15

2.  Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial.

Authors:  Carmen A Pfortmueller; Anna S Messmer; Benjamin Hess; David Reineke; Laura Jakob; Stefanie Wenger; Jan Waskowski; Patrick Zuercher; Frederik Stoehr; Gabor Erdoes; Markus M Luedi; Stephan M Jakob; Lars Englberger; Joerg C Schefold
Journal:  Trials       Date:  2019-06-14       Impact factor: 2.279

Review 3.  Intravenous and Oral Fluid Therapy in Neonatal Calves With Diarrhea or Sepsis and in Adult Cattle.

Authors:  Peter D Constable; Florian M Trefz; Ismail Sen; Joachim Berchtold; Mohammad Nouri; Geoffrey Smith; Walter Grünberg
Journal:  Front Vet Sci       Date:  2021-01-27

4.  Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery.

Authors:  Bjoern Zante; Hermann Reichenspurner; Mathias Kubik; Stefan Kluge; Joerg C Schefold; Carmen A Pfortmueller
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.